Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boston secret stent plan alleged in Medinol fraud suit

This article was originally published in Clinica

Executive Summary

In a bizarre twist to the often acrimonious war of words surrounding negotiations between Boston Scientific and its stent supplier Medinol, Medinol has filed a lawsuit in the US. The suit has caused Boston's share dealings to be suspended. It involves not only the company, but also the senior management, including co-founder Peter Nicholas, who are accused of fraud.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts